US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cellectar Biosciences

3.51

+0.03000.86%

Post-market: 3.510.00000.00%16:10 EST

Volume:13.79K

Turnover:47.43K

Market Cap:14.88M

PE:-0.33

High:3.59

Open:3.59

Low:3.38

Close:3.48

52wk High:20.59

52wk Low:2.45

Shares:4.24M

Float Shares:4.06M

Volume Ratio:0.84

T/O Rate:0.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-10.6249

EPS(LYR):-41.8902

ROE:-145.42%

ROA:-72.31%

PB:1.99

PE(LYR):-0.08

Loading ...

Overview Company News Filings

Cellectar Says FDA Grants Rare Pediatric Drug Designation for Iopofosine in High-Grade Glioma

MT Newswires Live

Cellectar Biosciences Inc - May Receive Priority Review Voucher

THOMSON REUTERS

Cellectar Biosciences Receives Rare Pediatric Disease Designation From U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma

THOMSON REUTERS

Cellectar Biosciences Inc expected to post a loss of $2.76 a share - Earnings Preview

Cellectar Biosciences files to sell 2.1M shares of common stock for holders

Cellectar Biosciences presents posters at AACR on CLR 121225, CLR 225

Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research

Cellectar Biosciences Raises $5.8M Through Warrant Exercise

Cellectar BioSciences raises 58 million from warrant exercises and issues new inducement warrants totaling 1048094 shares

BRIEF-Cellectar Biosciences, Inc. Enters Into Agreements To Raise $5.8 Million

EMA news ‘a substantial positive catalyst’ for Cellectar, says Oppenheimer

BRIEF-Cellectar wins EMA nod to seek conditional approval for Iopofosine in rare blood cancer

Cellectar Biosciences : Potential 2027 European Approval and Commercial Launch of Iopofosine I 131 as a Treatment for Refractory (Post-Btki) Wm

THOMSON REUTERS

Cellectar Biosciences Inc - Cma Application for Iopofosine I 131 Expected in Early 2026

THOMSON REUTERS

Cellectar Biosciences Announces European Medicines Agency (Ema) Confirms Eligibility to File for Conditional Marketing Authorization (Cma) for Iopofosine I 131 as a Treatment for Refractory (Post-Btki) Waldenstrom Macroglobulinemia (Wm)

THOMSON REUTERS

Cellectar Biosciences Announces European Medicines Agency (EMA) Confirms Eligibility to File for Conditional Marketing Authorization (CMA) for Iopofosine I 131 as a Treatment for Refractory (post-BTKi) Waldenstrom Macroglobulinemia (WM)

Oppenheimer Remains a Hold on Cellectar Biosciences (CLRB)

Cellectar Biosciences Presented Compelling Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer

Cellectar, Evestia entered into agreement for Phase 1b study of CLR 125

Cellectar and Evestia Clinical Announce Partnership to Support Auger-Emitting Radiopharmaceutical Clinical Trial in Triple-Negative Breast Cancer (TNBC)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CLRB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLRB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLRB\",,,,,undefined,":{"symbol":"CLRB","market":"US","secType":"STK","nameCN":"Cellectar Biosciences","latestPrice":3.51,"timestamp":1772139600000,"preClose":3.48,"halted":0,"volume":13794,"hourTrading":{"tag":"盘后","latestPrice":3.51,"preClose":3.51,"latestTime":"16:10 EST","volume":73,"amount":256.22999999999996,"timestamp":1772140204175,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.008620689655172358,"floatShares":4059000,"shares":4240134,"eps":-10.6249,"marketStatus":"Post-Mkt","change":0.03,"latestTime":"02-26 18:17:05 EST","open":3.59,"high":3.59,"low":3.38,"amount":47430.0883,"amplitude":0.060345,"askPrice":3.82,"askSize":100,"bidPrice":3.4,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-10.6249,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772154000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.48,"preHourTrading":{"tag":"盘前","latestPrice":3.35,"preClose":3.48,"latestTime":"08:57 EST","volume":249,"amount":834.2399637,"timestamp":1772114276661,"change":-0.13,"changeRate":-0.037356,"amplitude":0.025862},"postHourTrading":{"tag":"盘后","latestPrice":3.51,"preClose":3.51,"latestTime":"16:10 EST","volume":73,"amount":256.22999999999996,"timestamp":1772140204175,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.843567,"impliedVol":1.1856,"impliedVolPercentile":0.9012},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLRB\",,,,,undefined,":{"symbol":"CLRB","floatShares":4059000,"roa":"-72.31%","roe":"-145.42%","lyrEps":-41.890175,"volumeRatio":0.843567,"shares":4240134,"dividePrice":0,"high":3.59,"amplitude":0.060345,"preClose":3.48,"low":3.38,"week52Low":2.45,"pbRate":"1.99","week52High":20.5947,"institutionHeld":0,"latestPrice":3.51,"committee":0.333333,"eps":-10.6249,"divideRate":0,"volume":13794,"delay":0,"ttmEps":-10.6249,"open":3.59,"prevYearClose":2.95,"prevWeekClose":3.38,"prevMonthClose":3.22,"prevQuarterClose":2.95,"fiveDayClose":3.41,"twentyDayClose":3.31,"sixtyDayClose":3.59,"earningDate":1772553600000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLRB\",params:#limit:5,,,undefined,":[{"date":"2026-03-04","symbol":"CLRB","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":-1.2,"defaultRemindTime":1772614800000,"name":null,"time":"Pre-Market","dateTimestamp":1772600400000,"actualEps":null},{"market":"US","date":"2025-11-13","symbol":"CLRB","fiscalQuarterEnding":"2025/09","expectedEps":-1.91,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-1.41},{"market":"US","date":"2025-08-14","symbol":"CLRB","fiscalQuarterEnding":"2025/06","expectedEps":-3.6,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-3.39},{"market":"US","date":"2025-06-24","symbol":"CLRB","defaultRemindTime":1750771800000,"type":"split","dateTimestamp":1750737600000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2025-05-13","symbol":"CLRB","fiscalQuarterEnding":"2025/03","expectedEps":-0.17,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLRB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLRB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.25,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1747544400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CLRB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CLRB","date":"2026-02-25","current":-0.324709,"percent":0.577017,"low":-6.725322,"twenty":-2.578565,"median":-0.9162,"eighty":-0.52694,"high":-0.193553,"avg":-1.473711,"sd":1.310323,"marketCap":14246850},"quantilePoints":[{"date":"2021-02-26","current":-5.688994,"twenty":-3.933888,"median":-1.525018,"eighty":-0.851303,"marketCap":84532759},{"date":"2021-03-05","current":-5.788461,"twenty":-4.336289,"median":-1.533081,"eighty":-0.855652,"marketCap":87372023},{"date":"2021-03-12","current":-6.524566,"twenty":-4.605776,"median":-1.533081,"eighty":-0.860994,"marketCap":98482917},{"date":"2021-03-19","current":-6.29035,"twenty":-4.800064,"median":-1.533081,"eighty":-0.866735,"marketCap":94947632},{"date":"2021-03-26","current":-5.587705,"twenty":-4.999409,"median":-1.535637,"eighty":-0.871509,"marketCap":84341780},{"date":"2021-04-01","current":-5.688083,"twenty":-5.070945,"median":-1.537698,"eighty":-0.879312,"marketCap":85856902},{"date":"2021-04-09","current":-4.951978,"twenty":-5.120251,"median":-1.548792,"eighty":-0.886486,"marketCap":74746008},{"date":"2021-04-16","current":-4.751222,"twenty":-5.120251,"median":-1.558853,"eighty":-0.891503,"marketCap":71715765},{"date":"2021-04-23","current":-5.32003,"twenty":-5.14475,"median":-1.559288,"eighty":-0.900071,"marketCap":80301455},{"date":"2021-04-30","current":-5.286571,"twenty":-5.169249,"median":-1.565438,"eighty":-0.909372,"marketCap":79796414},{"date":"2021-05-07","current":-4.75069,"twenty":-5.219653,"median":-1.572391,"eighty":-0.913472,"marketCap":71707727},{"date":"2021-05-14","current":-3.888071,"twenty":-5.219653,"median":-1.582988,"eighty":-0.918185,"marketCap":68016888},{"date":"2021-05-21","current":-4.430593,"twenty":-5.219653,"median":-1.590841,"eighty":-0.925029,"marketCap":77507616},{"date":"2021-05-28","current":-4.942975,"twenty":-5.219653,"median":-1.593621,"eighty":-0.925029,"marketCap":86471082},{"date":"2021-06-04","current":-4.671714,"twenty":-5.253112,"median":-1.593621,"eighty":-0.925029,"marketCap":81725718},{"date":"2021-06-11","current":-4.249753,"twenty":-5.253112,"median":-1.593621,"eighty":-0.925029,"marketCap":74344040},{"date":"2021-06-18","current":-3.827791,"twenty":-5.253112,"median":-1.593621,"eighty":-0.925029,"marketCap":66962362},{"date":"2021-06-25","current":-3.827791,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":66962362},{"date":"2021-07-02","current":-3.737371,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":65380574},{"date":"2021-07-09","current":-3.52639,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":61689735},{"date":"2021-07-16","current":-3.28527,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":57471634},{"date":"2021-07-23","current":-3.37569,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":59053422},{"date":"2021-07-30","current":-3.28527,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":57471634},{"date":"2021-08-06","current":-3.104429,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":54308058},{"date":"2021-08-13","current":-2.661348,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":52987012},{"date":"2021-08-20","current":-2.511279,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":49999161},{"date":"2021-08-27","current":-2.987265,"twenty":-5.239728,"median":-1.596896,"eighty":-0.925383,"marketCap":59475966},{"date":"2021-09-03","current":-3.160965,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":62934297},{"date":"2021-09-10","current":-3.191654,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":63545310},{"date":"2021-09-17","current":-3.099587,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":61712272},{"date":"2021-09-24","current":-2.999848,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":59726481},{"date":"2021-10-01","current":-2.790856,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":55565485},{"date":"2021-10-08","current":-2.606722,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":51899410},{"date":"2021-10-15","current":-2.814486,"twenty":-5.239728,"median":-1.605688,"eighty":-0.925383,"marketCap":56035965},{"date":"2021-10-22","current":-2.760474,"twenty":-5.239728,"median":-1.616414,"eighty":-0.925383,"marketCap":54960583},{"date":"2021-10-29","current":-2.645697,"twenty":-5.239728,"median":-1.622698,"eighty":-0.925383,"marketCap":52675396},{"date":"2021-11-05","current":-2.874023,"twenty":-5.239728,"median":-1.637244,"eighty":-0.925383,"marketCap":57221329},{"date":"2021-11-12","current":-2.424802,"twenty":-5.239728,"median":-1.64287,"eighty":-0.925383,"marketCap":52907581},{"date":"2021-11-19","current":-2.114246,"twenty":-5.239728,"median":-1.670829,"eighty":-0.925383,"marketCap":46131451},{"date":"2021-11-26","current":-2.024355,"twenty":-5.239728,"median":-1.697872,"eighty":-0.926071,"marketCap":44170100},{"date":"2021-12-03","current":-1.710999,"twenty":-5.239728,"median":-1.7177,"eighty":-0.926481,"marketCap":37332869},{"date":"2021-12-10","current":-2.175853,"twenty":-5.233037,"median":-1.731798,"eighty":-0.926567,"marketCap":47475679},{"date":"2021-12-17","current":-1.932225,"twenty":-5.233037,"median":-1.751184,"eighty":-0.932125,"marketCap":42159869},{"date":"2021-12-23","current":-1.960228,"twenty":-5.233037,"median":-1.764108,"eighty":-0.933139,"marketCap":42770882},{"date":"2021-12-31","current":-1.859416,"twenty":-5.233037,"median":-1.80397,"eighty":-0.933139,"marketCap":40571236},{"date":"2022-01-07","current":-1.931665,"twenty":-5.226345,"median":-1.843174,"eighty":-0.933273,"marketCap":42147649},{"date":"2022-01-14","current":-1.957148,"twenty":-5.226345,"median":-1.894678,"eighty":-0.933273,"marketCap":42703670},{"date":"2022-01-21","current":-1.512176,"twenty":-5.226345,"median":-1.894678,"eighty":-0.933273,"marketCap":32994680},{"date":"2022-01-28","current":-1.651912,"twenty":-5.226345,"median":-1.894678,"eighty":-0.933273,"marketCap":36043633},{"date":"2022-02-04","current":-1.597026,"twenty":-5.226345,"median":-1.880422,"eighty":-0.933273,"marketCap":34846048},{"date":"2022-02-11","current":-1.596186,"twenty":-5.226345,"median":-1.841635,"eighty":-0.933273,"marketCap":34827718},{"date":"2022-02-18","current":-1.365159,"twenty":-5.226345,"median":-1.799558,"eighty":-0.933273,"marketCap":29786864},{"date":"2022-02-25","current":-1.343876,"twenty":-5.226345,"median":-1.772988,"eighty":-0.933273,"marketCap":29322494},{"date":"2022-03-04","current":-1.313353,"twenty":-5.226345,"median":-1.754415,"eighty":-0.933273,"marketCap":28656490},{"date":"2022-03-11","current":-1.382521,"twenty":-5.226345,"median":-1.731798,"eighty":-0.933273,"marketCap":30165692},{"date":"2022-03-18","current":-1.512176,"twenty":-5.156037,"median":-1.7177,"eighty":-0.933273,"marketCap":32994680},{"date":"2022-03-25","current":-1.684679,"twenty":-5.125151,"median":-1.705459,"eighty":-0.933273,"marketCap":40638448},{"date":"2022-04-01","current":-1.747497,"twenty":-5.074166,"median":-1.705459,"eighty":-0.933273,"marketCap":42153759},{"date":"2022-04-08","current":-1.672015,"twenty":-5.004293,"median":-1.688068,"eighty":-0.933273,"marketCap":40332941},{"date":"2022-04-14","current":-1.744204,"twenty":-4.988062,"median":-1.677395,"eighty":-0.933273,"marketCap":42074327},{"date":"2022-04-22","current":-1.499772,"twenty":-4.928004,"median":-1.665722,"eighty":-0.933273,"marketCap":36178050},{"date":"2022-04-29","current":-1.35514,"twenty":-4.81659,"median":-1.653084,"eighty":-0.933273,"marketCap":32689168},{"date":"2022-05-06","current":-1.236093,"twenty":-4.81659,"median":-1.642551,"eighty":-0.933273,"marketCap":29817471},{"date":"2022-05-13","current":-0.971537,"twenty":-4.759432,"median":-1.633772,"eighty":-0.932431,"marketCap":23224585},{"date":"2022-05-20","current":-0.922973,"twenty":-4.707882,"median":-1.622321,"eighty":-0.926654,"marketCap":22063661},{"date":"2022-05-27","current":-1.124386,"twenty":-4.59731,"median":-1.616414,"eighty":-0.924784,"marketCap":26878439},{"date":"2022-06-03","current":-1.06317,"twenty":-4.527041,"median":-1.608334,"eighty":-0.924784,"marketCap":25415064},{"date":"2022-06-10","current":-0.988154,"twenty":-4.346201,"median":-1.599718,"eighty":-0.924784,"marketCap":23621804},{"date":"2022-06-17","current":-0.97895,"twenty":-4.102874,"median":-1.595839,"eighty":-0.922973,"marketCap":23401778},{"date":"2022-06-24","current":-1.052051,"twenty":-3.948352,"median":-1.589635,"eighty":-0.922973,"marketCap":25149274},{"date":"2022-07-01","current":-1.052307,"twenty":-3.872252,"median":-1.579478,"eighty":-0.922973,"marketCap":25155384},{"date":"2022-07-08","current":-1.139722,"twenty":-3.827791,"median":-1.572391,"eighty":-0.922973,"marketCap":27245047},{"date":"2022-07-15","current":-1.098824,"twenty":-3.749427,"median":-1.565438,"eighty":-0.922973,"marketCap":26267366},{"date":"2022-07-22","current":-1.265222,"twenty":-3.691644,"median":-1.559288,"eighty":-0.922973,"marketCap":30245118},{"date":"2022-07-29","current":-1.001954,"twenty":-3.538446,"median":-1.559288,"eighty":-0.922973,"marketCap":23951690},{"date":"2022-08-05","current":-1.249205,"twenty":-3.429942,"median":-1.546185,"eighty":-0.922973,"marketCap":31619886},{"date":"2022-08-12","current":-1.419387,"twenty":-3.357606,"median":-1.540179,"eighty":-0.922973,"marketCap":35927523},{"date":"2022-08-19","current":-1.389213,"twenty":-3.28527,"median":-1.537358,"eighty":-0.922973,"marketCap":35163757},{"date":"2022-08-26","current":-1.286645,"twenty":-3.192932,"median":-1.533081,"eighty":-0.922973,"marketCap":32567566},{"date":"2022-09-02","current":-1.264847,"twenty":-3.164709,"median":-1.533081,"eighty":-0.922973,"marketCap":32015822},{"date":"2022-09-09","current":-1.194892,"twenty":-3.130276,"median":-1.533081,"eighty":-0.922973,"marketCap":30245108},{"date":"2022-09-16","current":-1.136958,"twenty":-3.099587,"median":-1.530339,"eighty":-0.922973,"marketCap":28778679},{"date":"2022-09-23","current":-0.905221,"twenty":-3.052825,"median":-1.523319,"eighty":-0.922253,"marketCap":22912961},{"date":"2022-09-30","current":-0.811078,"twenty":-3.002917,"median":-1.516299,"eighty":-0.919318,"marketCap":20530013},{"date":"2022-10-07","current":-0.808664,"twenty":-2.963818,"median":-1.511365,"eighty":-0.913446,"marketCap":20468912},{"date":"2022-10-14","current":-0.50451,"twenty":-2.902195,"median":-1.509279,"eighty":-0.910753,"marketCap":12770157},{"date":"2022-10-21","current":-0.439334,"twenty":-2.829708,"median":-1.506875,"eighty":-0.901903,"marketCap":11120423},{"date":"2022-10-28","current":-0.778645,"twenty":-2.798958,"median":-1.502259,"eighty":-0.894438,"marketCap":19709071},{"date":"2022-11-04","current":-0.649648,"twenty":-2.772857,"median":-1.500323,"eighty":-0.88915,"marketCap":17738164},{"date":"2022-11-11","current":-0.653085,"twenty":-2.722212,"median":-1.495239,"eighty":-0.886133,"marketCap":17832016},{"date":"2022-11-18","current":-0.684021,"twenty":-2.666626,"median":-1.493772,"eighty":-0.878935,"marketCap":18676691},{"date":"2022-11-25","current":-0.65996,"twenty":-2.645329,"median":-1.492014,"eighty":-0.872388,"marketCap":18019722},{"date":"2022-12-02","current":-0.642774,"twenty":-2.617033,"median":-1.486496,"eighty":-0.866735,"marketCap":17550458},{"date":"2022-12-09","current":-0.603245,"twenty":-2.569255,"median":-1.481199,"eighty":-0.86055,"marketCap":16471152},{"date":"2022-12-16","current":-0.464034,"twenty":-2.517725,"median":-1.478305,"eighty":-0.85454,"marketCap":12670117},{"date":"2022-12-23","current":-0.53278,"twenty":-2.478119,"median":-1.47143,"eighty":-0.849991,"marketCap":14547171},{"date":"2022-12-30","current":-0.587777,"twenty":-2.449284,"median":-1.464554,"eighty":-0.84308,"marketCap":16048815},{"date":"2023-01-06","current":-0.635899,"twenty":-2.449284,"median":-1.457678,"eighty":-0.838184,"marketCap":17362753},{"date":"2023-01-13","current":-0.586058,"twenty":-2.449284,"median":-1.456169,"eighty":-0.826732,"marketCap":16001888},{"date":"2023-01-20","current":-0.519031,"twenty":-2.449284,"median":-1.453935,"eighty":-0.822266,"marketCap":14171760},{"date":"2023-01-27","current":-0.529343,"twenty":-2.449284,"median":-1.449641,"eighty":-0.811174,"marketCap":14453318},{"date":"2023-02-03","current":-0.567153,"twenty":-2.449284,"median":-1.441011,"eighty":-0.810112,"marketCap":15485698},{"date":"2023-02-10","current":-0.58434,"twenty":-2.449284,"median":-1.430175,"eighty":-0.799183,"marketCap":15954962},{"date":"2023-02-17","current":-0.574028,"twenty":-2.449284,"median":-1.425071,"eighty":-0.79354,"marketCap":15673404},{"date":"2023-02-24","current":-0.536218,"twenty":-2.449284,"median":-1.416973,"eighty":-0.786486,"marketCap":14641024},{"date":"2023-03-03","current":-0.646211,"twenty":-2.449284,"median":-1.411924,"eighty":-0.781744,"marketCap":17644311},{"date":"2023-03-10","current":-0.548305,"twenty":-2.449284,"median":-1.404643,"eighty":-0.776181,"marketCap":15682216},{"date":"2023-03-17","current":-0.517655,"twenty":-2.449284,"median":-1.395795,"eighty":-0.774082,"marketCap":14805570},{"date":"2023-03-24","current":-0.514249,"twenty":-2.449284,"median":-1.389315,"eighty":-0.768613,"marketCap":14708165},{"date":"2023-03-31","current":-0.487004,"twenty":-2.44707,"median":-1.388277,"eighty":-0.76466,"marketCap":13928925},{"date":"2023-04-06","current":-0.459759,"twenty":-2.449284,"median":-1.388216,"eighty":-0.761326,"marketCap":13149684},{"date":"2023-04-14","current":-0.469976,"twenty":-2.451499,"median":-1.386252,"eighty":-0.754745,"marketCap":13441899},{"date":"2023-04-21","current":-0.509788,"twenty":-2.451499,"median":-1.37818,"eighty":-0.751061,"marketCap":14580564},{"date":"2023-04-28","current":-0.519357,"twenty":-2.451499,"median":-1.37244,"eighty":-0.748983,"marketCap":14854273},{"date":"2023-05-05","current":-0.504032,"twenty":-2.451499,"median":-1.364402,"eighty":-0.736952,"marketCap":14415950},{"date":"2023-05-12","current":-0.442426,"twenty":-2.451499,"median":-1.363468,"eighty":-0.728012,"marketCap":13734114},{"date":"2023-05-19","current":-0.467528,"twenty":-2.451499,"median":-1.363468,"eighty":-0.723003,"marketCap":14513355},{"date":"2023-05-25","current":-0.480079,"twenty":-2.451499,"median":-1.363468,"eighty":-0.717726,"marketCap":14902975},{"date":"2023-06-02","current":-0.511457,"twenty":-2.453713,"median":-1.363468,"eighty":-0.71595,"marketCap":15877026},{"date":"2023-06-09","current":-0.552248,"twenty":-2.453713,"median":-1.363468,"eighty":-0.711716,"marketCap":17143292},{"date":"2023-06-16","current":-0.643244,"twenty":-2.453713,"median":-1.363468,"eighty":-0.707415,"marketCap":19968039},{"date":"2023-06-23","current":-0.608728,"twenty":-2.455927,"median":-1.363468,"eighty":-0.703804,"marketCap":18896583},{"date":"2023-06-30","current":-0.580488,"twenty":-2.455927,"median":-1.363468,"eighty":-0.701226,"marketCap":18019937},{"date":"2023-07-07","current":-0.621279,"twenty":-2.455927,"median":-1.363468,"eighty":-0.698648,"marketCap":19286203},{"date":"2023-07-14","current":-0.564799,"twenty":-2.455927,"median":-1.363468,"eighty":-0.695814,"marketCap":17532912},{"date":"2023-07-21","current":-0.621279,"twenty":-2.455927,"median":-1.364313,"eighty":-0.6926,"marketCap":19286203},{"date":"2023-07-28","current":-0.593667,"twenty":-2.455927,"median":-1.364313,"eighty":-0.689642,"marketCap":18429039},{"date":"2023-08-04","current":-0.555386,"twenty":-2.455927,"median":-1.364313,"eighty":-0.684662,"marketCap":17240697},{"date":"2023-08-11","current":-0.542835,"twenty":-2.455927,"median":-1.364313,"eighty":-0.682685,"marketCap":16851077},{"date":"2023-08-18","current":-0.489643,"twenty":-2.455927,"median":-1.364313,"eighty":-0.677154,"marketCap":15584811},{"date":"2023-08-25","current":-0.547788,"twenty":-2.455927,"median":-1.364313,"eighty":-0.671183,"marketCap":17435507},{"date":"2023-09-01","current":-0.541668,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":17240697},{"date":"2023-09-08","current":-0.703862,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":22403166},{"date":"2023-09-15","current":-0.621235,"twenty":-2.455927,"median":-1.364313,"eighty":-0.67029,"marketCap":19773229},{"date":"2023-09-22","current":-0.670199,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":21331710},{"date":"2023-09-29","current":-0.791504,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":25192695},{"date":"2023-10-06","current":-0.890343,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":28338644},{"date":"2023-10-13","current":-0.840359,"twenty":-2.455927,"median":-1.364313,"eighty":-0.67029,"marketCap":26747702},{"date":"2023-10-20","current":-0.821615,"twenty":-2.455927,"median":-1.364313,"eighty":-0.67029,"marketCap":26151099},{"date":"2023-10-27","current":-0.765383,"twenty":-2.455927,"median":-1.371024,"eighty":-0.671484,"marketCap":24361290},{"date":"2023-11-03","current":-0.749763,"twenty":-2.455927,"median":-1.371024,"eighty":-0.677154,"marketCap":23864121},{"date":"2023-11-10","current":-0.609182,"twenty":-2.455927,"median":-1.371024,"eighty":-0.680681,"marketCap":19389598},{"date":"2023-11-17","current":-0.526803,"twenty":-2.455927,"median":-1.371024,"eighty":-0.67632,"marketCap":19886768},{"date":"2023-11-24","current":-0.68359,"twenty":-2.455927,"median":-1.371024,"eighty":-0.67632,"marketCap":25805482},{"date":"2023-12-01","current":-0.804032,"twenty":-2.455927,"median":-1.371024,"eighty":-0.67632,"marketCap":30352162},{"date":"2023-12-08","current":-0.817053,"twenty":-2.455927,"median":-1.368092,"eighty":-0.676472,"marketCap":30843695},{"date":"2023-12-15","current":-0.862626,"twenty":-2.455927,"median":-1.368092,"eighty":-0.676472,"marketCap":32564061},{"date":"2023-12-22","current":-0.859371,"twenty":-2.455927,"median":-1.368092,"eighty":-0.677154,"marketCap":32441178},{"date":"2023-12-29","current":-0.810543,"twenty":-2.459512,"median":-1.371066,"eighty":-0.68359,"marketCap":30597929},{"date":"2024-01-05","current":-0.921219,"twenty":-2.463098,"median":-1.371108,"eighty":-0.684208,"marketCap":34775959},{"date":"2024-01-12","current":-1.119786,"twenty":-2.463098,"median":-1.371108,"eighty":-0.687735,"marketCap":42271838},{"date":"2024-01-19","current":-1.152338,"twenty":-2.466683,"median":-1.371634,"eighty":-0.695517,"marketCap":43500670},{"date":"2024-01-26","current":-1.168614,"twenty":-2.463098,"median":-1.371108,"eighty":-0.696611,"marketCap":44115086},{"date":"2024-02-02","current":-3.170245,"twenty":-2.47556,"median":-1.37216,"eighty":-0.698541,"marketCap":119676525},{"date":"2024-02-09","current":-2.83144,"twenty":-2.511321,"median":-1.382521,"eighty":-0.705287,"marketCap":106886667},{"date":"2024-02-16","current":-2.895974,"twenty":-2.559581,"median":-1.389315,"eighty":-0.71595,"marketCap":109322830},{"date":"2024-02-23","current":-2.702372,"twenty":-2.602292,"median":-1.395777,"eighty":-0.722058,"marketCap":102014340},{"date":"2024-03-01","current":-3.162178,"twenty":-2.640716,"median":-1.403441,"eighty":-0.725922,"marketCap":119372004},{"date":"2024-03-08","current":-3.28318,"twenty":-2.654096,"median":-1.410827,"eighty":-0.740082,"marketCap":123939810},{"date":"2024-03-15","current":-2.726572,"twenty":-2.68046,"median":-1.424856,"eighty":-0.740082,"marketCap":102927901},{"date":"2024-03-22","current":-3.121844,"twenty":-2.705602,"median":-1.438947,"eighty":-0.740082,"marketCap":117849402},{"date":"2024-03-28","current":-2.914244,"twenty":-2.737044,"median":-1.450802,"eighty":-0.740082,"marketCap":110693172},{"date":"2024-04-05","current":-3.159506,"twenty":-2.768117,"median":-1.453935,"eighty":-0.738597,"marketCap":120009097},{"date":"2024-04-12","current":-3.151013,"twenty":-2.795029,"median":-1.457678,"eighty":-0.738597,"marketCap":119686492},{"date":"2024-04-19","current":-2.581962,"twenty":-2.80756,"median":-1.464554,"eighty":-0.738597,"marketCap":98071950},{"date":"2024-04-26","current":-2.564976,"twenty":-2.8074,"median":-1.472805,"eighty":-0.740082,"marketCap":97426740},{"date":"2024-05-03","current":-3.152301,"twenty":-2.818244,"median":-1.479044,"eighty":-0.740082,"marketCap":119735406},{"date":"2024-05-10","current":-3.057921,"twenty":-2.825242,"median":-1.48319,"eighty":-0.740082,"marketCap":116150513},{"date":"2024-05-17","current":-2.341465,"twenty":-2.840499,"median":-1.488219,"eighty":-0.740082,"marketCap":119376916},{"date":"2024-05-24","current":-2.151616,"twenty":-2.840499,"median":-1.492706,"eighty":-0.740082,"marketCap":109697707},{"date":"2024-05-31","current":-2.137553,"twenty":-2.840499,"median":-1.493972,"eighty":-0.740082,"marketCap":108980728},{"date":"2024-06-07","current":-2.130522,"twenty":-2.840499,"median":-1.493972,"eighty":-0.740082,"marketCap":108622239},{"date":"2024-06-14","current":-2.362559,"twenty":-2.842268,"median":-1.495239,"eighty":-0.738597,"marketCap":120452384},{"date":"2024-06-21","current":-1.968799,"twenty":-2.844036,"median":-1.493972,"eighty":-0.737113,"marketCap":100376987},{"date":"2024-06-28","current":-1.638322,"twenty":-2.848813,"median":-1.495239,"eighty":-0.734086,"marketCap":83527992},{"date":"2024-07-05","current":-1.736762,"twenty":-2.848813,"median":-1.495239,"eighty":-0.734086,"marketCap":88546842},{"date":"2024-07-12","current":-1.736762,"twenty":-2.848813,"median":-1.502259,"eighty":-0.734086,"marketCap":88546842},{"date":"2024-07-15","current":-1.778951,"twenty":-2.848813,"median":-1.502259,"eighty":-0.734086,"marketCap":90697777},{"date":"2024-08-02","current":-1.448474,"twenty":-2.858906,"median":-1.499353,"eighty":-0.726559,"marketCap":73848783},{"date":"2024-08-09","current":-1.357065,"twenty":-2.858906,"median":-1.492382,"eighty":-0.726559,"marketCap":69188423},{"date":"2024-08-16","current":-1.427379,"twenty":-2.858906,"median":-1.489129,"eighty":-0.726559,"marketCap":72773315},{"date":"2024-08-23","current":-1.469568,"twenty":-2.858906,"median":-1.486189,"eighty":-0.726559,"marketCap":74924251},{"date":"2024-08-30","current":-1.539882,"twenty":-2.858906,"median":-1.496239,"eighty":-0.726559,"marketCap":78509143},{"date":"2024-09-06","current":-1.476599,"twenty":-2.858906,"median":-1.504725,"eighty":-0.726559,"marketCap":75282740},{"date":"2024-09-13","current":-1.483631,"twenty":-2.858906,"median":-1.492706,"eighty":-0.726559,"marketCap":75641229},{"date":"2024-09-20","current":-1.483631,"twenty":-2.858906,"median":-1.488453,"eighty":-0.726559,"marketCap":75641229},{"date":"2024-09-27","current":-1.343002,"twenty":-2.858906,"median":-1.483631,"eighty":-0.726559,"marketCap":68471444},{"date":"2024-10-04","current":-1.518788,"twenty":-2.858906,"median":-1.488453,"eighty":-0.726559,"marketCap":77433675},{"date":"2024-10-11","current":-1.476599,"twenty":-2.858906,"median":-1.49236,"eighty":-0.726559,"marketCap":75282740},{"date":"2024-10-18","current":-1.448474,"twenty":-2.858906,"median":-1.49236,"eighty":-0.726559,"marketCap":73848783},{"date":"2024-10-25","current":-1.476599,"twenty":-2.858906,"median":-1.49236,"eighty":-0.726559,"marketCap":75282740},{"date":"2024-10-31","current":-1.525463,"twenty":-2.858906,"median":-1.4952,"eighty":-0.726559,"marketCap":73490294},{"date":"2024-11-08","current":-1.57011,"twenty":-2.859722,"median":-1.504725,"eighty":-0.725908,"marketCap":75641229},{"date":"2024-11-15","current":-1.360507,"twenty":-2.859722,"median":-1.504725,"eighty":-0.734143,"marketCap":72056337},{"date":"2024-11-22","current":-1.27916,"twenty":-2.859722,"median":-1.504725,"eighty":-0.743515,"marketCap":64095123},{"date":"2024-11-29","current":-1.268391,"twenty":-2.859722,"median":-1.504725,"eighty":-0.743515,"marketCap":63555538},{"date":"2024-12-06","current":-1.120138,"twenty":-2.859722,"median":-1.504725,"eighty":-0.743515,"marketCap":56126968},{"date":"2024-12-13","current":-0.217439,"twenty":-2.859722,"median":-1.504725,"eighty":-0.734143,"marketCap":10895235},{"date":"2024-12-20","current":-0.196024,"twenty":-2.859722,"median":-1.504725,"eighty":-0.707279,"marketCap":9822219},{"date":"2024-12-27","current":-0.25269,"twenty":-2.859722,"median":-1.504725,"eighty":-0.696611,"marketCap":12661583},{"date":"2025-01-03","current":-0.267598,"twenty":-2.859722,"median":-1.499772,"eighty":-0.678312,"marketCap":13408567},{"date":"2025-01-10","current":-0.256149,"twenty":-2.860519,"median":-1.4952,"eighty":-0.672905,"marketCap":12834917},{"date":"2025-01-17","current":-0.199483,"twenty":-2.860519,"median":-1.490662,"eighty":-0.663943,"marketCap":9995552},{"date":"2025-01-24","current":-0.200884,"twenty":-2.860519,"median":-1.483631,"eighty":-0.656377,"marketCap":10065711},{"date":"2025-01-31","current":-0.205084,"twenty":-2.860519,"median":-1.476599,"eighty":-0.653085,"marketCap":10276187},{"date":"2025-02-07","current":-0.227322,"twenty":-2.860519,"median":-1.469568,"eighty":-0.649765,"marketCap":11390473},{"date":"2025-02-14","current":-0.258415,"twenty":-2.860519,"median":-1.462536,"eighty":-0.649371,"marketCap":12948445},{"date":"2025-02-21","current":-0.307523,"twenty":-2.860519,"median":-1.455889,"eighty":-0.646211,"marketCap":15409110},{"date":"2025-02-28","current":-0.264392,"twenty":-2.860519,"median":-1.455557,"eighty":-0.642751,"marketCap":13247964},{"date":"2025-03-07","current":-0.281773,"twenty":-2.861316,"median":-1.455505,"eighty":-0.637961,"marketCap":14118874},{"date":"2025-03-14","current":-0.30967,"twenty":-2.861316,"median":-1.455505,"eighty":-0.627475,"marketCap":13805530},{"date":"2025-03-21","current":-0.392876,"twenty":-2.861316,"median":-1.455505,"eighty":-0.621802,"marketCap":17514960},{"date":"2025-03-28","current":-0.372307,"twenty":-2.861316,"median":-1.455505,"eighty":-0.618851,"marketCap":16597970},{"date":"2025-04-04","current":-0.303055,"twenty":-2.861316,"median":-1.455505,"eighty":-0.611866,"marketCap":13510619},{"date":"2025-04-11","current":-0.281969,"twenty":-2.860519,"median":-1.452002,"eighty":-0.605839,"marketCap":12570589},{"date":"2025-04-17","current":-0.292719,"twenty":-2.860519,"median":-1.452002,"eighty":-0.600469,"marketCap":13049820},{"date":"2025-04-25","current":-0.323417,"twenty":-2.861316,"median":-1.455505,"eighty":-0.592686,"marketCap":14418392},{"date":"2025-05-02","current":-0.27308,"twenty":-2.861316,"median":-1.455505,"eighty":-0.58434,"marketCap":12174302},{"date":"2025-05-09","current":-0.259953,"twenty":-2.861316,"median":-1.455505,"eighty":-0.579875,"marketCap":11589088},{"date":"2025-05-16","current":-0.476316,"twenty":-2.861316,"median":-1.455505,"eighty":-0.57508,"marketCap":11690464},{"date":"2025-05-23","current":-0.473125,"twenty":-2.861316,"median":-1.455505,"eighty":-0.567153,"marketCap":11612128},{"date":"2025-05-30","current":-0.495654,"twenty":-2.861316,"median":-1.455505,"eighty":-0.564172,"marketCap":12165087},{"date":"2025-06-06","current":-0.766199,"twenty":-2.861316,"median":-1.448474,"eighty":-0.561109,"marketCap":18805196},{"date":"2025-06-13","current":-0.820458,"twenty":-2.861316,"median":-1.434963,"eighty":-0.561109,"marketCap":20136905},{"date":"2025-06-20","current":-0.686218,"twenty":-2.862113,"median":-1.434411,"eighty":-0.560832,"marketCap":16842194},{"date":"2025-06-27","current":-0.544863,"twenty":-2.862113,"median":-1.427379,"eighty":-0.560279,"marketCap":13372840},{"date":"2025-07-03","current":-0.354382,"twenty":-2.862113,"median":-1.415815,"eighty":-0.559226,"marketCap":8697782},{"date":"2025-07-11","current":-0.36398,"twenty":-2.862113,"median":-1.406445,"eighty":-0.554197,"marketCap":8933347},{"date":"2025-07-18","current":-0.578544,"twenty":-2.862113,"median":-1.392222,"eighty":-0.551409,"marketCap":14199478},{"date":"2025-07-25","current":-0.622778,"twenty":-2.862113,"median":-1.37818,"eighty":-0.551409,"marketCap":15285153},{"date":"2025-08-01","current":-0.563411,"twenty":-2.862113,"median":-1.370772,"eighty":-0.55032,"marketCap":13828063},{"date":"2025-08-08","current":-0.548278,"twenty":-2.862113,"median":-1.356102,"eighty":-0.549652,"marketCap":13456648},{"date":"2025-08-15","current":-0.485305,"twenty":-2.862113,"median":-1.344156,"eighty":-0.548278,"marketCap":14108816},{"date":"2025-08-22","current":-0.492991,"twenty":-2.862113,"median":-1.329467,"eighty":-0.5438,"marketCap":14332259},{"date":"2025-08-29","current":-0.514951,"twenty":-2.862113,"median":-1.314652,"eighty":-0.542135,"marketCap":14970667},{"date":"2025-09-05","current":-0.546792,"twenty":-2.86291,"median":-1.30524,"eighty":-0.539697,"marketCap":15896359},{"date":"2025-09-12","current":-0.579731,"twenty":-2.862113,"median":-1.284536,"eighty":-0.539697,"marketCap":16853971},{"date":"2025-09-19","current":-0.602789,"twenty":-2.862113,"median":-1.278581,"eighty":-0.539697,"marketCap":17524299},{"date":"2025-09-26","current":-0.631336,"twenty":-2.862113,"median":-1.269728,"eighty":-0.539697,"marketCap":18354230},{"date":"2025-10-03","current":-0.636826,"twenty":-2.862113,"median":-1.261912,"eighty":-0.539697,"marketCap":18513832},{"date":"2025-10-10","current":-0.523735,"twenty":-2.862113,"median":-1.245054,"eighty":-0.538608,"marketCap":15226030},{"date":"2025-10-17","current":-0.521539,"twenty":-2.862113,"median":-1.210068,"eighty":-0.538088,"marketCap":15162190},{"date":"2025-10-24","current":-0.415035,"twenty":-2.862113,"median":-1.192478,"eighty":-0.536386,"marketCap":12065911},{"date":"2025-10-31","current":-0.35794,"twenty":-2.862113,"median":-1.167076,"eighty":-0.534695,"marketCap":10406050},{"date":"2025-11-07","current":-0.376606,"twenty":-2.862113,"median":-1.150447,"eighty":-0.531595,"marketCap":10948697},{"date":"2025-11-14","current":-0.315119,"twenty":-2.862113,"median":-1.138828,"eighty":-0.528413,"marketCap":9161154},{"date":"2025-11-21","current":-0.634293,"twenty":-2.862113,"median":-1.127224,"eighty":-0.52694,"marketCap":11957177},{"date":"2025-11-28","current":-0.807487,"twenty":-2.862113,"median":-1.120099,"eighty":-0.52694,"marketCap":15222081},{"date":"2025-12-05","current":-0.854721,"twenty":-2.85129,"median":-1.109333,"eighty":-0.52694,"marketCap":16112509},{"date":"2025-12-12","current":-0.850223,"twenty":-2.823373,"median":-1.100993,"eighty":-0.52694,"marketCap":16027706},{"date":"2025-12-19","current":-0.609551,"twenty":-2.814978,"median":-1.081228,"eighty":-0.52694,"marketCap":11490763},{"date":"2025-12-26","current":-0.620797,"twenty":-2.805842,"median":-1.065406,"eighty":-0.52694,"marketCap":11702769},{"date":"2026-01-02","current":-0.663533,"twenty":-2.792758,"median":-1.056217,"eighty":-0.52694,"marketCap":12508395},{"date":"2026-01-09","current":-0.744507,"twenty":-2.75581,"median":-1.047962,"eighty":-0.52694,"marketCap":14034843},{"date":"2026-01-16","current":-0.820982,"twenty":-2.721585,"median":-1.029047,"eighty":-0.52694,"marketCap":15476489},{"date":"2026-01-23","current":-0.85697,"twenty":-2.702372,"median":-1.013967,"eighty":-0.52694,"marketCap":16154910},{"date":"2026-01-30","current":-0.728762,"twenty":-2.669266,"median":-0.996329,"eighty":-0.52694,"marketCap":13738034},{"date":"2026-02-06","current":-0.634293,"twenty":-2.645451,"median":-0.960674,"eighty":-0.52694,"marketCap":11957177},{"date":"2026-02-13","current":-0.70627,"twenty":-2.633205,"median":-0.924507,"eighty":-0.52694,"marketCap":13314020},{"date":"2026-02-20","current":-0.767,"twenty":-2.603613,"median":-0.920946,"eighty":-0.52694,"marketCap":14458856},{"date":"2026-02-25","current":-0.755753,"twenty":-2.578565,"median":-0.9162,"eighty":-0.52694,"marketCap":14246850}],"updateTime":1772126585688},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLRB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2578414806","title":"Cellectar Says FDA Grants Rare Pediatric Drug Designation for Iopofosine in High-Grade Glioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2578414806","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578414806?lang=en_us&edition=fundamental","pubTime":"2025-10-27 21:12","pubTimestamp":1761570760,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences  said Monday that the US Food and Drug Administration has granted its investigational drug iopofosine I 131 rare pediatric drug designation as a potential treatment for inoperable relapsed or refractory pediatric high-grade glioma.Pediatric high-grade gliomas are a collection of aggressive brain and central nervous system tumors.A phase 1b study of the radioactive isotope treatment showed meaningful improvements in progression-free and overall survival, the company said.The study showed that six patients who received at least a 55 millicurie dose of the treatment experienced an average of 5.4 months of progression-free survival and 8.6 months of overall survival, the company said.Three patients who received additional dosing had an average progression-free survival of 8.1 months and overall survival of 11.5 months, the company added.The treatment was well-tolerated, and its toxicity profile was consistent with the company's previously reported safety data, Cellect","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2578764644","title":"Cellectar Biosciences Inc - May Receive Priority Review Voucher","url":"https://stock-news.laohu8.com/highlight/detail?id=2578764644","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578764644?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:30","pubTimestamp":1761568202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUA9GKV1W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2578364615","title":"Cellectar Biosciences Receives Rare Pediatric Disease Designation From U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2578364615","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578364615?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:30","pubTimestamp":1761568202,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUA9GKV1W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2578540260","title":"Cellectar Biosciences Inc  expected to post a loss of $2.76 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2578540260","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578540260?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:35","pubTimestamp":1761338105,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences Inc  expected to post a loss of $2.76 a share - Earnings Preview Cellectar Biosciences Inc CLRB.OQ CLRB.O is expected to  show no change in quarterly revenue when it reports  res","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nL8N3W5282:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2577899558","title":"Cellectar Biosciences files to sell 2.1M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2577899558","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577899558?lang=en_us&edition=fundamental","pubTime":"2025-10-21 05:30","pubTimestamp":1760995812,"startTime":"0","endTime":"0","summary":"17:27 EDT Cellectar Biosciences (CLRB) files to sell 2.1M shares of common stock for holders Published first on TheFly – the ultimate source for re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cellectar-biosciences-files-to-sell-2-1m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cellectar-biosciences-files-to-sell-2-1m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2575621841","title":"Cellectar Biosciences presents posters at AACR on CLR 121225, CLR 225","url":"https://stock-news.laohu8.com/highlight/detail?id=2575621841","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575621841?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:36","pubTimestamp":1760445386,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences (CLRB) announced that Jarrod Longcor, chief operating officer of Cellectar, presented positive preclinical data in a poster a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cellectar-biosciences-presents-posters-at-aacr-on-clr-121225-clr-225-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cellectar-biosciences-presents-posters-at-aacr-on-clr-121225-clr-225-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLRB","BK4213","CLR","BK4139"],"gpt_icon":0},{"id":"2575218515","title":"Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2575218515","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575218515?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:30","pubTimestamp":1760445000,"startTime":"0","endTime":"0","summary":"CLR 225 (225Ac-phospholipid ether) Demonstrates Meaningful Inhibition of Tumor Growth and Potential Survival Benefit In Three Pancreatic Cancer Xenograft ModelsFLORHAM PARK, N.J., Oct.  14, 2025  (GLO","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/14/3166189/29076/en/Cellectar-Biosciences-Presented-Promising-Preclinical-Data-in-Poster-Presentation-at-the-American-Association-for-Cancer-Research-AACR-Special-Conference-on-Pancreatic-Cancer-Resea.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2240825500.USD","LU2125910179.SGD","CNS","LU0289739343.SGD","AFG","BK4585","LU1923621640.USD","LU2211814178.USD","BK4120","LU0511384066.AUD","CLRB","LU2362541513.USD","LU0175139822.USD","LU0289961442.SGD","LU1989772923.USD","WM","LU2355687059.USD","LU1585245621.USD","LU2362540622.SGD","LU1712237335.SGD","LU2413666699.HKD","BK4534","LU0124676726.USD","LU2023250504.SGD","LU2362541273.HKD","LU2041044095.USD","BK4121","BK4533","LU2106854487.HKD","LU1917777945.USD","LU2092937221.SGD","LU1989772840.SGD","LU0057025933.USD","LU2463526074.USD","BK4135","LU1939255532.USD","LU0289960550.SGD","LU1623119135.USD","LU2298064838.USD","EMA","LU2238339852.HKD","BK4081","LU2125910336.SGD","LU2413666426.HKD","BK4588","BK4139","LU2023250843.SGD","LU1721428933.USD","LU0347712357.USD","SEER"],"gpt_icon":0},{"id":"2574657488","title":"Cellectar Biosciences Raises $5.8M Through Warrant Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2574657488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574657488?lang=en_us&edition=fundamental","pubTime":"2025-10-11 05:02","pubTimestamp":1760130145,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences ( ($CLRB) ) has provided an update. On October 7, 2025, Cellectar Biosciences entered into warrant exercise inducement offer ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cellectar-biosciences-raises-5-8m-through-warrant-exercise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cellectar-biosciences-raises-5-8m-through-warrant-exercise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2574107184","title":"Cellectar BioSciences raises 58 million from warrant exercises and issues new inducement warrants totaling 1048094 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2574107184","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574107184?lang=en_us&edition=fundamental","pubTime":"2025-10-11 04:31","pubTimestamp":1760128283,"startTime":"0","endTime":"0","summary":"Cellectar BioSciences Inc. entered into inducement offer agreements with certain holders of existing warrants originally issued on October 25, 2022, July 21, 2024, and July 2, 2025. The holders agreed to exercise warrants for cash to purchase 1,048,094 shares of common stock at an exercise price of $5.25 per share. Additionally, holders paid $0.125 per new inducement warrant. The company received approximately $5.8 million in gross proceeds from these transactions, which closed on October 8, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectar BioSciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDL3d3Ggj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2573950980","title":"BRIEF-Cellectar Biosciences, Inc. Enters Into Agreements To Raise $5.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2573950980","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573950980?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:48","pubTimestamp":1759841304,"startTime":"0","endTime":"0","summary":"BRIEF-Cellectar Biosciences, Inc. Enters Into Agreements To Raise $5.8 MillionOct 7 (Reuters) - Cellectar Biosciences Inc CLRB.O:CELLECTAR BIOSCIENCES, INC. ENTERS INTO AGREEMENTS TO RAISE $5.8 MILLIONSource text: ID:nGNX8116S6Further company coverage: CLRB.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nTUA2CLWZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2573080786","title":"EMA news ‘a substantial positive catalyst’ for Cellectar, says Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2573080786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573080786?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:55","pubTimestamp":1759758927,"startTime":"0","endTime":"0","summary":"Oppenheimer notes Cellectar Biosciences (CLRB) announced receipt of feedback from the Scientific Advice Working Party of the European Medicines Age...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ema-news-a-substantial-positive-catalyst-for-cellectar-says-oppenheimer-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ema-news-a-substantial-positive-catalyst-for-cellectar-says-oppenheimer-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","OPY","CLRB","BK4139","EMA","BK4081"],"gpt_icon":0},{"id":"2573794456","title":"BRIEF-Cellectar wins EMA nod to seek conditional approval for Iopofosine in rare blood cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2573794456","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573794456?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:09","pubTimestamp":1759748953,"startTime":"0","endTime":"0","summary":"BRIEF-Cellectar wins EMA nod to seek conditional approval for Iopofosine in rare blood cancerOct 6 (Reuters) - Cellectar Biosciences Inc CLRB.O:CELLECTAR BIOSCIENCES ANNOUNCES EUROPEAN MEDICINES AGENC","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUAHX56:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2573679972","title":"Cellectar Biosciences : Potential 2027 European Approval and Commercial Launch of Iopofosine I 131 as a Treatment for Refractory (Post-Btki) Wm","url":"https://stock-news.laohu8.com/highlight/detail?id=2573679972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573679972?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:00","pubTimestamp":1759748401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUAHX56:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2573679155","title":"Cellectar Biosciences Inc - Cma Application for Iopofosine I 131 Expected in Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2573679155","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573679155?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:00","pubTimestamp":1759748401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUAHX56:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2573467950","title":"Cellectar Biosciences Announces European Medicines Agency (Ema) Confirms Eligibility to File for Conditional Marketing Authorization (Cma) for Iopofosine I 131 as a Treatment for Refractory (Post-Btki) Waldenstrom Macroglobulinemia (Wm)","url":"https://stock-news.laohu8.com/highlight/detail?id=2573467950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573467950?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:00","pubTimestamp":1759748401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUAHX56:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2573067947","title":"Cellectar Biosciences Announces European Medicines Agency (EMA) Confirms Eligibility to File for Conditional Marketing Authorization (CMA) for Iopofosine I 131 as a Treatment for Refractory (post-BTKi) Waldenstrom Macroglobulinemia (WM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2573067947","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573067947?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:00","pubTimestamp":1759748400,"startTime":"0","endTime":"0","summary":"Following Scientific Advice and Guidance from Scientific Advice Working Party (SAWP) of EMA, Submission of CMA Application for Iopofosine I 131 as a Treatment for Refractory (post-BTKi) WM Expected in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/06/3161577/29076/en/Cellectar-Biosciences-Announces-European-Medicines-Agency-EMA-Confirms-Eligibility-to-File-for-Conditional-Marketing-Authorization-CMA-for-Iopofosine-I-131-as-a-Treatment-for-Refra.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","WM","MDCO","LU2362540622.SGD","BK4533","LU2092937221.SGD","IE00BD6J9T35.USD","CNS","LU2362541273.HKD","LU0868494708.USD","LU1430594728.SGD","CHMP","LU0069063385.USD","LU0511384066.AUD","BK4079","EMA","BK4520","BK4120","BK4534","BK4567","CAT","LU1585245621.USD","LU2413666699.HKD","PDCO","LU1989772923.USD","LU2125910336.SGD","LU2362541513.USD","LU1623119135.USD","LU2089279066.USD","LU1712237335.SGD","LU2264538146.SGD","LU1923621640.USD","LU2463526074.USD","CMA","LU2125910179.SGD","BK4516","CLRB","COMP","LU2237438978.USD","LU2238339852.HKD","LU2229751404.USD","PRAC","LU0942090050.USD","LU1064131342.USD","BK4589","LU0057025933.USD","BK4566","LU1988902786.USD","LU1989772840.SGD","ORR"],"gpt_icon":0},{"id":"2572141505","title":"Oppenheimer Remains a Hold on Cellectar Biosciences (CLRB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2572141505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572141505?lang=en_us&edition=fundamental","pubTime":"2025-10-02 19:55","pubTimestamp":1759406123,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst maintained a Hold rating on Cellectar Biosciences today. The company’s shares closed yesterday at $5.77. Cellectar Biosciences ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-remains-a-hold-on-cellectar-biosciences-clrb-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-remains-a-hold-on-cellectar-biosciences-clrb-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","BK4127","CLRB","BK4139"],"gpt_icon":0},{"id":"2571470073","title":"Cellectar Biosciences Presented Compelling Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2571470073","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571470073?lang=en_us&edition=fundamental","pubTime":"2025-09-30 20:30","pubTimestamp":1759235400,"startTime":"0","endTime":"0","summary":"CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma Patients Showed Extended Progression-Free Survival and Overall SurvivalFLORHAM PARK, N.J.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/30/3158606/29076/en/Cellectar-Biosciences-Presented-Compelling-Data-in-Oral-Session-and-Panel-Discussions-at-the-American-Association-for-Cancer-Research-Special-Conference-on-Discovery-and-Innovation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4211","BK4097","BK4107","ORR","CLRB","AFG","OS","DHG","BK4117","CNS","BK4195","PFS","BK4139"],"gpt_icon":0},{"id":"2569701168","title":"Cellectar, Evestia entered into agreement for Phase 1b study of CLR 125","url":"https://stock-news.laohu8.com/highlight/detail?id=2569701168","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569701168?lang=en_us&edition=fundamental","pubTime":"2025-09-24 20:40","pubTimestamp":1758717614,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences (CLRB) and Evestia Clinical have entered into an agreement whereby Evestia will provide Cellectar with full CRO services for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cellectar-evestia-entered-into-agreement-for-phase-1b-study-of-clr-125-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cellectar-evestia-entered-into-agreement-for-phase-1b-study-of-clr-125-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLRB","BK4213","BK4139","CLR"],"gpt_icon":0},{"id":"2569013797","title":"Cellectar and Evestia Clinical Announce Partnership to Support Auger-Emitting Radiopharmaceutical Clinical Trial in Triple-Negative Breast Cancer (TNBC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2569013797","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569013797?lang=en_us&edition=fundamental","pubTime":"2025-09-24 20:30","pubTimestamp":1758717000,"startTime":"0","endTime":"0","summary":"Intends to Initiate Phase 1b Clinical Trial in TNBC at Mayo Clinic in Fourth Quarter 2025FLORHAM PARK, N.J. and LONDON and CHARLOTTESVILLE, Va., Sept.  24, 2025  (GLOBE NEWSWIRE) -- Cellectar Bioscien","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/24/3155463/29076/en/Cellectar-and-Evestia-Clinical-Announce-Partnership-to-Support-Auger-Emitting-Radiopharmaceutical-Clinical-Trial-in-Triple-Negative-Breast-Cancer-TNBC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNS","BK4135","CLRB"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}]}}